Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I was a little confused because your posts made it seem that Enzolytics was an SEC regulated company. Like they were actually required to report to shareholders. They were not and are currently not SEC Reporting and they are currently listed as OTC Pink. While they were listed as an OTC Pink before they received their Yield Sign. What's it been 3 years running that they have achieved a Yield Sign, or is it more than that? I would have liked to see more details about what is going on whether it is Harry, Charles, or Steve in charge. I don't need the CEO to hold my hand on an "investment", but if all I'm receiving is press releases about hopes and dreams without any fulfillment then something is wrong.
That is the right and legal way of doing it. I’m a sure there are legal OTC protocols for them to follow. Obviously ENZC management people did not follow it. There are legal repercussion which await to be brought out to light.
And yet here you are
Nope. You would have known if a hundred million shares of $10 SAGA stock had been dumped before the delisting as it was a Nasdaq trading stock at that time.
That’s not how any of this works. Welcome to the reality of “investing” in otc stocks. You knew (or should have) the risk before putting money in.
"ENZC management should have put out a PR letting everyone (general public and sharehlders) know what their plan was..."
If that had happened, then the general public (that is, all non-shareholders) would have developed a negative opinion of ENZC, and the shareholders would not have had any buyers for their shares, and the shares would have plunged in value.
Essentially another empty otc shell with billions of trash shares and still worth half a penny each, quite impressive lol
"The link you provided was for fiscal year 2011 to 2012."
How do I find out the CURRENT number of shares outstanding?
archilles. Wondering if they gave themselves a “Golden Parachute” at the expense of the shareholders???
I wonder if the five management (Charles, Chandra, Harry, Joe and ?) cashed out their SAGA shares at $10.80 before SAGA management purposely not filed or failed to file correctly with SEC so that SAGA get delisted and SAGA shares become worthless for the ENZC shareholders?
So crooked !
Yes of course, Details of filing are a must for a SEC regulated company. I was explaining it on a high level. It is a short education for shareholders here on this forum. It appears some shareholders here are willing to accept what has happened either they do not care or because they dont understand their rights as a shareholder or because the bashers have misled them so much with their lies
No, ENZC management should have put out a PR letting everyone (general public and sharehlders) know what their plan was and set an execution schedule and dates so that shareholders can make a decision what to do. I can tell you this right now, No shareholders and the general public would allow officers of any company to take the IPs that were developed while they were employed under that company to go somewhere else and open up their own company.
That is stealing and robbing of shareholders as the value of the company gets diminished when the valueable IPs are taken away.
I suspect what have happened was agreed and planned out by the pact of four without putting out a PR prior to their plans and action.
I’ll bet you anything that Charles, Joe and Chandra didn’t take any SAGA shares (or voided their end of the deal / returned them) and walked from this knowing all the issues it faced.
If it was an SEC reporting company they would have been required to file an 8K within 5 days of a material event. ENZC is not SEC Reporting. As to shareholder agreement on any change (whether minor or major) that would depend on the share structure and voting rights. It has nothing to do with whether they are listed on NASDAQ or OTC, or whether or not they are an SEC Reporting company to the best of my knowledge. If the party of four owned the majority of voting rights, then yes they could divide up the company any way they wanted. The four gave up their preferred shares for the SAGA deal, so do they have majority voting rights? Do the two that have currently voted have the voting rights after the SPAC deal? Was the SPAC deal valid?
Everything about where the SAGA deal is NOW is based upon Sagaliam illegally issuing shares to the 5 management of ENZC so that they could sway the vote for Sagaliam to buy ENZOLYTICS. So illegal!
Was ENZC supposed to notify ONLY the shareholders (and not the general public) about these future developments, so that the shareholders would have the chance to sell ENZC shares before the shares plunged in price?
If yes, would that not be illegal insider trading?
Sorry, otc pink stocks do not need to notify shareholders in advance of things like this and only need to put things in the quarterly and yearly filings.
Let me see if I understand this situation.
Charles Cotropia, Joseph Cotropia, and Chandra, collectively, have more ENZC shares than Harry Z. But Harry Z is now claiming that he is in control of ENZC and that the Cotropias and Chandra are not in control. Harry Z's claim is false, and the Cotropias and Chandra may sue him for control of ENZC.
Is my understanding correct?
If Harry Z does take control of ENZC, would that constitute a change of control as described in the Enzolytics SAFE?
To refresh everyone's memory, the SAFE defines "change of control" as follows:
“change of control” means (i) a transaction or series of related transactions in which any “person” or “group” (within the meaning of Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of more than 50% of the outstanding voting
securities of the Company having the right to vote for the election of members of the Company’s board of directors, (ii) any reorganization, merger or consolidation of the Company, other than a transaction or series of related transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after such transaction or seriesof related transactions, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity or (iii) a sale, lease or other disposition of all or substantially all of the assets of the Company.
If ENZC was a NASDAQ company, management must notify shareholders and ask whether if shareholders would agree to any of these major changes by casting shareholders votes. If majority of votes came back say no, No changes can take place
....But ENZC is not a NASDAQ. It is an OTC company, ENZC management must have at least notify shareholders of the changes in advance so that shareholders can decide if they want to stay on or sell. They should have notified shareholders in advance that Charles and Chandra leaving ENZC and take ENZC IPs else where to open their own company.
They never notify shareholders of any of these changes which made so much impact on shareholders money and lifelines.
For these reasons, they have broken shareholders trust and violated legalities that shareholders must band together and go after.
There are so much more things (empty promises SAGA deal..etc) that ENZC including former CEO Charles and Chandra have violated and must be brought out to light
Definitely after you buy all shares.
"I suspect Harry will not go after the IP because the party of four (Charles, Harry, Chandra and Joe) has made a pact and divided up the IPs and wealth among themselves."
If the party of four, collectively, owned a majority of the shares of ENZC, then did these four people not have the legal right to divide up the ENZC IP in any way they wished?
I understand. It also pointed out exactly how Charles had changed over the years . We trusted Charles but Charles has changed, got greedy and stole from ENZC shareholders. Look at the PPS, it took a dump and long shareholders got panicked, sold at bottom price and lost monies. When the announcement came out that Charles has left Enzc, and discovery of his new company and Chandra’s new company, stock took a big dump. Shareholders got panicked and sold at bottom price and lost their shirts.
There is no need to go back in time to show what Charles was like 13 years ago. What important now is that Charles is an dishonest person who stole from Enzc shareholders.
I highly suspect the pact of four will continue with more dishonesty by putting out PRs to pull other shareholders money back in and sell more shares after they successfully convert preferred A shares to common shares
I was asked how well Charles had run BioClonetics before the merger with Enzolytics. I invested into BioClonetics in 2017. BioClonetics merged with Enzolytics in late 2020. From the time I invested in 2017 to the end of 2020, Charles was great at providing updates.
The link that I provided pointed to the number of Shares Outstanding. I used that number to calculate how many shares I would get in a change of control.
The link you provided was for fiscal year 2011 to 2012. Maybe Charles was younger and honest then, but he is not honest nowadays because Charles never disclosed the new company that he and others are currently running after he left ENZC. Charles also took with him the Clone7 Ip developed during his employment under Enzc. The clone 7 IP belongs to Enzc and Enzc shareholders. It is not his to take away for opening his new company. I suspect Harry will not go after the IP because the party of four (Charles, Harry, Chandra and Joe) has made a pact and divided up the IPs and wealth among themselves. Harry got the control of ENZC. Charles and Chandra took the valuable IPs from ENZC shareholders to open up their own companies.
1) As head of BioClonetics, Charles gave many updates on what was happening with the company. So, from the update standpoint, Charles was very good.
2) number of shares of Enzolytics
Common Stock after change of control
= purchase amount / liquidity price
= purchase amount / (valuation cap / number of shares outstanding)
= $200 / ($6,000,000 / 2,440,000,000)
= 81333 and 1/3 shares
source for number of shares outstanding - https://finance.yahoo.com/quote/ENZC/key-statistics?p=ENZC (Shares Outstanding, NOT Implied Shares Outstanding)
The problem with not providing links to back stuff up good or bad is that when credible sources are not used to show that bad information is true, a majority of people won't believe it. I've seen this recently with iglow (no offense and this is why I call you out on some of your posts), who has posted some good info that upon checking is a negative for the company. If I didn't know any better and did not check I would just think that user was bashing because no source was provided. You can call me whatever you want.
If you want to know the relationship between Harry and Charles, Please read the following post written by Valuator2. For those who have not read or know the significance of it, It appeared there was a Four-way agreement between Charles, Harry, Chandra and Joe. I suspect that the group agreed to have ENZC company control relinquished to Harry. The agreement also allowed Charles and Chandra separated from ENZC and ran off to create their own new companies while the SAGA deal was happening. All these agreements were done behind close doors without any notifications to ENZC shareholders. ENZC shareholders have no votes or says against any of these agreements as Charles and Charles ran off with IPs developed while they were employed under ENZC
Valuator2’s post # 197xxx read
….,,“Harry got control of ENZC by virtue of the adjustments in the Series A Preferred stock when they negotiated the BCA with SAGA. You can see this by looking at the BCA and comparing stock ownership disclosures in the 2023 3Q and the 2023 Annual Report which includes the 4Q.
IMO, the relinquishment of control of ENZC to Harry had to be by agreement among them because the adjustment in the Series A structure was a part of the 9 million SAGA shares (ie, 20% off the top of the 45 million shares for the subs) the 4 principals got in the SAGA deal. Look at the numbers. They each gave 11.7 million Series A's in exchange for 2.25 million SAGA shares. That left Harry's Trust with 7.2 million Series A's and the Cotropia's and Chandra with zero Series A's, leaving Harry's Trust (and this Mr. Paul) as the only owners of Series A Preferred and, thus, in control of ENZC. Prior to this agreement, the Cotropia's and Chandra controlled ENZC with 35.1 million to Harry's Trust's 18.9 million Series A Preferred. (When and how Paul got the Series A's is unknown...must have come from Harry or his Trust somehow, but they aren't disclosed on the Schedule on p. 25 of the Annual Report.) JMHO.
Another indicator of cooperation IMO is that Chandra did not have an equal number of Series A's or Series B's with the Cotropia's, but he got an equal number of SAGA shares as CC, JC and Harry...2.25 million. So, it looks like CC and JC gave him some of their shares (both Series A's and B's) to make his share totals equal to theirs. So, CC, JC and Chandra exchanged all of their Series A's (11.7 each, totaling 35.1 million shares) and Harry's Trust put up the same number of Series A's (11.7 million), leaving his Trust with the remaining 7.2 million. JMHO.
I also thought it would be just a matter of time after the closure with SAGA that CC, JC and Chandra would resign from ENZC and focus on BGEN, leaving Harry in control of ENZC. So, I'm not surprised about their leaving ENZC. The filings say the Cotropia's and Chandra were "removed" as officers and directors of ENZC on March 25, which is 6 days after the 3/19 special meeting and about 30 days before these filings. (Why the 30 day delay to report the Cotropia's and Chandra are out?) That's a harsh way to describe their exit from ENZC but was it for cause or camouflage for what was agreed anyway? JMHO.“…
The whale and many of the others (pugsie, darron, etc.) would throw out a negative statement with nothing to back it up daily (sometimes multiple times a day). The empty office story at the time the whale told it was frustrating, but is now looking to be correct (again nothing to back it up at the time or now). If these users had supplied links to factual information on the opinion they were offering they would have been a lot more credible. I don't care if Timing agrees with me or not, Timing appears to be looking at this objectively and is not posting random BS.
....... Agree, noted doesn't always mean agree. I asked why didn't you TAKE NOTES from the whistle blowers. Didn't have to agree lol. I seem to remember a few little arguments with YOU and how this was a pump and dump and you didn't agree then either. That was in the .10-.15 range...... Maybe you need some notes on how to take notes?
Nice try , read my posts .. more to come . Noted does not always mean agree.
Noted? Why didnt you take notes from the whale or iglow?? That sticky whale had about an empty office was pretty close to nailing this story eh? Pumpers will pump and the suckers sucked it all up lol.
Noted on all points, it looks like you are not defending anybody , which is fine, apparently time to move on for some. Some one or something has been holding up many things here, it is about to come out.
BGEN doesn't own any assets - if so post the patents.
From BioClonetics Immunotherapeutics
INTELLECTUAL PROPERTY
The Company protects its technology through an aggressive strategy to cover its intellectual property. Such intellectual property includes:
PROPRIETARY CELL LINE PRODUCING CLONE 3
- The Company’s Clone 3 cell line, that produces fully human monoclonal
antibodies (mAbs) that specifically target and neutralize the HIV-1 virus, is
proprietary to the Company.
INTELLECTUAL PROPERTY PORTFOLIO
- Pending patent coverage on the recombinant of the Clone 3 antibody. This form of the Clone 3 antibody is prepared using the known amino acid sequence of the Antibody in conjunction with a high producing CHO cell line for generating recombinant
material that would ultimately be used in patient application.
- Pendintg Patent coverage of small molecules (mini-peptides) for commercial use derived from the structure of the Clone 3 antibody for interrupting and preventing binding between the HIV virus and the human CD4+ cell.
- Coverage is directed to blocking peptides that bind to and neutralize the HIV virus, and
- Competitive peptides that bind to the target CD4+ cells at the point of virus access into the human cell to prevent infection.
When you file a provisional patent - which excludes any prior art - it is a 12 month placeholder and you are allowed to use the term patent pending.
Here is an example:
Patent number: 6083504
InventorJoseph P. Cotropia
Assignee BIOCLONETICS IMMUNOTHERAPEUTICS Inc
Status: Expired
Then we have Patent Number 5777074
InventorJoseph P. Cotropia
Assignee BIOCLONETICS IMMUNOTHERAPEUTICS Inc
Status: Expired
US6008044A - and it has expired.
BIOCLONETICS Immunotherapeutics is a empty shell without any IP.
IG
I'm not going to defend Harry. I know many on here will say that Charles was trying to clean up Harry's mess, I'm not saying that you are stating that. How many years has Charles been at Enzolytics acting as the CEO? How many times have the required quarterly/annual filings been late? How many yield signs have there been? Who was in charge of making sure the audits and uplisting occurred? Who announced the non-binding agreement with the SPAC? Who should have done the due diligence on the SPAC and caught the fact that they only had $19 and a few potential NASDAQ violations before it turned into a binding agreement? Who was there when the non-binding agreement changed to a binding agreement? Who was there when it was announced the "transaction is complete"? The list could go on, but I think I've made the point.
"Charles Cotropia, Enzolytics' CEO, said, "We have a well-defined strategy and the necessary technology in place for producing numerous therapeutics for successfully treating numerous viruses that affect patients around the world. Completing the business combination with Sagaliam comes at a critical time. By providing additional funding to Biogenysis and Virogentics, this combination will make possible the final development of the numerous therapeutics now being produced.""
https://www.otcmarkets.com/stock/ENZC/news/Enzolytics-Announces-the-Signing-of-the-Business-Combination-Agreement-with-Sagaliam-Acquisition-Corp-SAGA?id=414494
You're right. I guess I was "jumping the gun" on that one.
Noted.. Bottom line is it appears that CC, GC and JC have had enough of Harry Z , Harry's past , Harry's continued issue of "ISSUING" shares all over the place. It is not surprising really, Even in a Marriage, when you tried to make it work over and over , after time it is just a decision to make and move forward.
--
In this CASE , NO ONE knows what is going on behind the scenes with Charles, Guarav and Joe C other than they have put Energy towards another source. It might have been a relief to have Harry Z post in a PR and disclosure they were "REMOVED" and SPECIAL MEETING (behind Bulgarian Closed Doors) . CMON , Harry is backed into a corner and when people get there , they do things out of desperation.
The notification of late filing isn't due until May 15th I believe.
I didn't she was or wasn't a front for someone else. I don't know if she fronts for Billy Ray Miller, James Zimbler, Paul Fellegy, Felizian Paul, or any of the other names that are associated with this company. I was stating that she was involved with Enzolytics long before the current annual report. Was it a "business loan" or "payroll protection program" loan? There were a lot of employes at that residential address that housed what was it 5 businesses? I'm not sticking up for Kelli in any way. If anyone needs more info about her, there were quite a few posts about her in late November 2023. I am still finding it odd that the share count of the convertible note to Camelot Nevada was able to change after a being reported at 14 million four times in required OTC quarterly/annual filings. I guess if I loaned money to a company that I didn't think would pay it back I would also want the number of shares increased and have them declared at a specified price. 56,600,000 x $0.005 =
My concerns as well. Here we have SAGA saying all IP is still in BGEN and it has left SAGA for ENZC. So now I guess we need to know whether everything was in BGEN when it arrived at ENZC (a silly question, but important to confirm given the recent activity). JMHO.
We need a definitive PR from ENZC about exactly what assets it has, including what's in BGEN and what they plan to do with it. Further, we need to know the status of CC and JC with BGEN and the 2022 and 2023 assignments of the 3 patent applications to BGEN. JMHO.
Where is the 2024 ENZC 1Q Report and financials?
AGreed BigItalian . All signals point to negative movement on any SAGA outcome. As predicted Barry K . is not in any way shape or form an upfront business person from all his past and records . From the beginning , I have said and provide many links here and always asked "How did Barry K . come along and who was the connection that brought him". It all appers to be Harry Z and when the PR's started coming out with just Harry Z and Barry K on them about what VIRO was doing only, Bulgaria involvement, Africa ... it SEALED IT completely . This started back a few months ago , long before this change of control came about and has been brewing since end of 2023.
--
https://www.otcmarkets.com/stock/ENZC/news/Virogentics-Inc-Receives-Permit-for-Export-to-Africa-of-the-ITV-1-Immunotherapy-Solidifying-the-Scheduled-Administration?id=410092
I agree with your assessment of "significant legal issues" if Chandra and Charles did indeed take BGEN IP with them. "Company right of ownership" would be the main legal issue since ENZC paid their salaries and funded the development. The Supreme Court established this some time again.
What I do not know is if an employee contract can supersede main stream "right of ownership.
MAGA, My take is Harry Z is scrambling at this point. Also that whole "change of Control" with Preferred A holders Zhabilov Trust (Diana) and that name from the past Felizian Paul just stinks . In reality the Preferred A Shareholders of Charles , Chandra and Joe C far outnumbered the Zhabilov Trust and there has never been any disclosure of :
a. CC, Chandra and Joe C selling ANY shares at ANYTIME .
b. Nor a disclosure saying CEO resigning
--
This is a pure Zhabilov move having his ATM control of Shares going every which a way he wants . Look for more to come here and would not be surprised if Charles and Team have a legal surprise in the Making. For SURE Chandra DID NOT GIVE UP any AI rights , that was all his from beginning , hence the ADNEXUS start , he can do what ever he wants with the AI ! Charles knows that and that is why ADNEXUS shows his (CC) address protecting it for Chandra!
--
I don't see that happening. I think the only reason SAGA still exists is because of the lawsuit they are currently in. The articles of inception (original and revised) of the SPAC SAGA stated clearly there were deadlines and criteria they had to meet otherwise they would need to start the de-SPAC process. Missing an extension deadline, in my opinion, should have triggered the start of the de-SPAC process. From what I've been seeing lately whoever it is that is running these companies (ENZC, SAGA, BGEN, VIRO, etc) are doing whatever they want to do and does not feel the need to follow rules, laws, or abide by contracts.
"The funds that SPACs raise in an IPO are placed in an interest-bearing trust account that cannot be disbursed except to complete an acquisition. In the event it is unable to complete an acquisition, funds will be returned and the SPAC will ultimately be liquidated.
A SPAC has two years to complete a deal or face liquidation. In some cases, some of the interest earned from the trust can serve as the SPAC’s working capital. After an acquisition, a SPAC is usually listed on one of the major stock exchanges."
"There are any number of reasons why a SPAC deal might fail.
The SPAC may not be able to find a suitable acquisition target in time. This can happen if the SPAC’s management team is not able to identify a private company that fits the investment criteria outlined in the SPAC’s prospectus, or if the private company is not interested in being acquired by the SPAC.
The SPAC’s management team may not be able to negotiate favorable terms for the acquisition, such as the purchase price or the structure of the deal.
The SPAC may not be able to raise enough capital through the IPO to fund the acquisition. This can happen if there is not enough investor interest in the SPAC, or if market conditions are unfavorable.
Finally, the SPAC deal can fail if the acquisition is not approved by the SPAC’s shareholders or by regulatory authorities."
"What happens if a SPAC does not merge?
SPACs have a specific time frame in which they need to merge with another company and close a deal. This time frame is usually 18 to 24 months. If a SPAC cannot merge during the allotted time, then it liquidates and all funds are returned to investors."
https://www.investopedia.com/terms/s/spac.asp
NO , Kelli Austin is a front person for Billy R , and Zhabilov that goes WAY Back .
This is what happens when folks do not do the LINKS I provide (NO IMO's ever) and at least look at the documentation. !!!
-
She is Camelot Nevada which ia a fake front , and I have posted various things with LINKS . That $283,000 was a fradulent payment during Corona Virus for a "Business Loan" also posted that prior with links . She has been converting shares on behalf of those two for some time . Here is one of them . BAD NEWS KELLI !! BEWARE has been a Zhabilov puppet front fake person for years.
--
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173281577
==
Here is more , READ and WEAP for falling for Kelli Austin prior to this .
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173265447
==
Folks do your DD and at least check them in GOOGLE , FIRST ! Kelli Austin has been a crook for years even in her CPA supposed business. Do some RESEARCH !
https://www.bbb.org/us/tx/mont-belvieu/profile/tax-return-preparation/austin-accounting-and-tax-0915-90045259
This is my question as well TJ24. To the best of my knowledge, BGEN is in control of Clone 3 & AI Platform. However, with the last PR stating that BGEN was going back under ENZC, I find it hard (almost impossible) to believe that BGEN retains ownership of C3/AI platform at the same time Charles & Chandra step away from both BGEN & ENZC. Would Charles really leave his crown-jewel (C3) behind with BGEN and step away? Very unclear and murky, as we've grown accustomed to with ENZC.
Anyway, my point is that I too, would really like to know the answer to this question. The answer would determine whether or not I buy back in or wave farewell to ENZC forever. C3, along with my "original belief" about Charles (That he was an honest CEO who had shareholders best interest in mind), are the main reasons I held 3-4 years+, instead of cashing out what would have been life-changing $$$ for me. Biggest lesson I've learned since I began trading, and still hard to swallow.
My dilemma is that I still believe in C3, but:
1. We've heard nothing about it in years. What happened to the tests? What happened with ENZO the monkey? Was he cured?
2. Does BGEN own C3 now, and if so, will BGEN move forward under ENZC, or will they screw us with some other SPAC/selling off to somebody else?
3. What is Charles role in all of this? If BGEN does own C3, I just can't see Charles allowing C3 to move forward without him.
Anyway, like I said, murky at best.
That's what I was musing about last week. I think Kostiner and Catropia are still thick as thieves, and that BGEN and MABS-Tech will merge with a new SAGA SPAC offer, but not so overtly as I just wrote it. (Something like that. I think its hail-Mary for SAGA to move ahead with Clone3/7, and be elusive to legal claims from ENZC or its shareholders.)
The 56 million was bothering me, as I remembered it being 14 million. I looked into it, and it's funny how easily the numbers can change. Good thing leadership never went SEC reporting, they may have been held accountable.
2022 annual shows 14 million
https://www.otcmarkets.com/otcapi/company/financial-report/366963/content
2023 1st quarter shows 14 million
https://www.otcmarkets.com/otcapi/company/financial-report/371665/content
2023 2nd quarter shows 14 million
https://www.otcmarkets.com/otcapi/company/financial-report/379987/content
2023 3rd quarter shows 14 million
https://www.otcmarkets.com/otcapi/company/financial-report/387028/content
Then in the 2023 annual it shows a conversion rate of 56.6 million with a price of $0.005
https://www.otcmarkets.com/otcapi/company/financial-report/398912/content
Valuator2,
My opinionated analysis is based on all the PR infomation (and/or lack of any opposing information) provided to ENZC shareholders so far and also was based on your post number 197524 in which you suspect that the control of ENZC was relinquished back to Harry under the 4-way agreement between Charles, Joes, Chandra and Harry.
Despite that the fact that Charles is lawyer, the party of four (Charles, Joes, Chandra and Harry) think that all of them can get away with doing the "bad" things because ENZC is an OTC stock which is not being subject to the SEC regulation enforcement, and also perhaps because they have not yet received any real legal challenges from any of its ENZC shareholders. They also know that ENZC shareholders do not have any voting rights to oppose any of their plans.
We recently know that Charles and Chandra have already detached themselves from ENZC and successfully founded their own new companies without telling ENZC shareholders and without any regards to the terms of the transaction with SAGA as they founded their own companies. Is it greed for is it because Charles is running out of time as his age is 80 year and he does not have much time left to do what he planned to set out to do.
p/s: I am responsible for drawing my personal opinion independently from Dyno89 whose posts I dont read and already ignored
Followers
|
1245
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
200034
|
Created
|
01/07/10
|
Type
|
Free
|
Moderators Homebrew Timing101 archilles SeniorApollo |
Independent Valuation Report Pre Clinical Studies
Investments
___________________________________________________________________________________
Press Release July 20-2021
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc.
for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
https://www.creative-biolabs.com/
https://finance.yahoo.com/news/enzolytics-announces-signing-letter-intent-113000339.htm
________________________________________
Press release July 21-2021
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and
Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
https://www.lonza.com/
https://www.bloomberg.com/press-releases/2021-07-21/enzolytics-and-lonza-bioscience-combine-technologies-to-fast-track-development-and-production-of-anti-hiv-and-anti-sar
_________________________________________
July 22 INTERVIEW
with
James Hicks, Charles Cotropia and Gurav Chandra
http://www.youtube.com/watch?v=mdljO9VLgj0
______________________________________________________________
COLLEGE STATION, TX August 25, 2021
Important Excerpt from this news progress update.
>>>>>><<<<<<
"The monoclonal antibodies being produced by Enzolytics against the CoronaVirus target 19 conserved immutable sites on the virus, sites which the Company has now confirmed are conserved sites not only on the initial virus strains but also existing in the Delta and Lambda variants, as well as in the Alpha, Beta and Gamma variants."
Enzolytics Inc. and Samsung Biologics Announce
Development and Manufacturing Agreement for Anti-
HIV and Anti-SARS-CoV-2
Important Excerpt from this news progress update.
>>>>>><<<<<<
"Samsung Biologics (KRX: 207940. K.S.), a leading contract development and manufacturing organization and Enzolytics (ENZC), a drug development company committed to commercializing multiple proprietary therapeutics to treat debilitating infectious diseases, announced the signing of a strategic CDMO partnership agreement."_______
2000 North Central Expressway
Plano, TX 75074
972-292-9414
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |